Groundbreaking Womb Cancer Test Gives Women New Hope and Confidence in NHS Care
A less invasive womb cancer screening test is being trialled in Suffolk and Essex, earning praise from patients who say it proves women's health is finally being taken seriously.
A Simple Swab Is Changing the Way Hospitals Detect Womb Cancer
For many women, a visit to a gynaecology clinic can be an anxiety-inducing experience — particularly when invasive and potentially painful procedures are on the table. But a new diagnostic test currently being trialled at hospitals in Suffolk and Essex is transforming that experience, and patients are taking notice.
Angela Ransby, a 56-year-old from Ipswich, is one of those patients. After living with endometriosis for two decades, she knows all too well what it feels like to face difficult, uncomfortable medical procedures. When she attended Ipswich Hospital following an episode of post-menopausal bleeding, she braced herself for more of the same — but what she encountered was something far more encouraging.
Meet the WID-Easy Test: Faster, Less Invasive, and More Accurate
Instead of the traditional ultrasound scan she anticipated, Ransby was offered the chance to participate in a trial of a new test called WID-easy — a straightforward vaginal swab, similar in nature to a routine smear test. The experience left her genuinely moved.
"If you'd have come in a week ago or two weeks ago, we wouldn't have been able to offer you what we can offer you now," her doctor told her at the time.
The WID-easy test involves collecting a swab from the vagina and behind the cervix. Results are typically returned within three to five days — a significant improvement over the weeks patients previously had to wait. Crucially, a negative result carries a very low probability of the patient developing womb cancer, while a positive result triggers prompt follow-up testing and treatment planning.
The East Suffolk and North Essex NHS Foundation Trust (ESNEFT) is the first trust in the East of England to trial this innovative approach, with both Ipswich Hospital and Colchester Hospital participating in the programme.
Why the Old Approach Was Falling Short
Previously, women presenting with symptoms like post-menopausal bleeding would typically undergo ultrasound scans as a first step. While useful, ultrasound carried a notable drawback: it produced false positive results with some regularity, leading many women to undergo unnecessary invasive procedures as a follow-up.
Dr Wendy MacNab, Clinical Director for Gynaecology at ESNEFT and a consultant gynae-oncologist, explained that this was a key motivation for adopting the new test.
"Why would I want to offer, as a gynaecologist, a less effective service?" she said. "When I can offer something that's quicker, less invasive, more accurate, and less uncomfortable to go through."
For Dr MacNab, embracing the WID-easy test was, in her own words, "a no brainer."
A Patient's Perspective: Feeling Heard and Valued
For Angela Ransby, the significance of the trial went beyond clinical efficiency. Her history with endometriosis has been nothing short of harrowing — the condition caused what she described as "debilitating" and "indescribable" pain over the years. She underwent a partial hysterectomy and bowel resection, and the disease eventually spread to her lungs.
After years of difficult experiences within women's healthcare, being offered a gentler, more advanced option at Ipswich Hospital felt like a turning point.
"It's not my experience to go to women's health in the NHS and come out thinking, 'Bloody hell, that was good, that was even tolerable,'" she admitted candidly.
But this time was different. When asked whether the trial had given her confidence that women's health was being taken seriously in her area, her response was unequivocal: "It genuinely does."
She has since become a vocal advocate for the test. "I'm telling everybody — I'm a real champion of it now," she said, adding that she recognises the emotional toll placed not only on patients but on the healthcare professionals who must regularly perform uncomfortable procedures. "If you're a practitioner giving it and you're seeing multiple women that you're hurting, that's tough."
The Wider Impact: More Patients Seen, More Quickly
Beyond individual patient experience, the WID-easy test has meaningful implications for NHS capacity. By streamlining the diagnostic process and reducing the need for follow-up invasive procedures, the test allows gynaecology teams to see more patients in less time — a vital advantage given ongoing pressures on healthcare services.
Dr MacNab noted that the response from colleagues across different hospital departments has been overwhelmingly positive.
"It's been a really busy few months setting it up, but it's also been a real pleasure to introduce something that seems to have such a positive response," she said. "Lots of people in other departments have said, 'Doesn't that sound like such a good thing to be doing?' There's a little positive glow we've all got from it."
A Step Forward for Women's Health
The WID-easy trial represents more than just a medical advancement — it signals a meaningful shift in how women's healthcare is approached, prioritising patient comfort, diagnostic accuracy, and timely results. For patients like Angela Ransby, that shift is long overdue, and deeply welcome.
